{"id":"CHEMBL1073","canonicalSmiles":"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1","inchiKey":"ZJJXGWJIGJFDTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIPIZIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glibenese","Glipizide","Glucotrol","Glucotrol xl","Minodiab 2.5","Minodiab 5"],"synonyms":["CP-28,720","CP-28720","Glipizide","K 4024","K-4024"],"crossReferences":{"DailyMed":["glipizide"],"PubChem":["11111214","11112714","144203707","144212151","170465089","50104189","56422485","855947"],"Wikipedia":["Glipizide"],"drugbank":["DB01067"],"chEBI":["5384"]},"count":4,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003884","EFO_0001360","EFO_0000400"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL1076347","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1","inchiKey":"ICUTUKXCWQYESQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOCARBAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tcc soap"],"synonyms":["TCC","Triclocarban"],"crossReferences":{"PubChem":["124892764","144205631","144209228","144210799","170465481","26757451","85148633"],"Wikipedia":["Triclocarban"],"drugbank":["DB11155"],"chEBI":["48347"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1078178","canonicalSmiles":"N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1","inchiKey":"ZVHNDZWQTBEVRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMELOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT-0387","CYT-11387","CYT-387","CYT387","Cyt-387","GS-0387","Momelotinib"],"crossReferences":{"PubChem":["137275866"],"drugbank":["DB11763"]},"childChemblIds":["CHEMBL2219411"],"count":6,"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_0002430","MONDO_0044903","EFO_0002517","EFO_0002429","EFO_0003060","EFO_0000479"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1085765","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl","inchiKey":"GJNMJOHYRWHJQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE DIHCL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1623","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meclizine diHCl"],"crossReferences":{"PubChem":["50125651","855589"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1086","canonicalSmiles":"CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1","inchiKey":"PUFQVTATUTYEAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nupercainal"],"synonyms":["Cinchocaine","Dibucaine"],"crossReferences":{"PubChem":["11112228","144203932","170464829","50100394","50100395","56424123","855529"],"Wikipedia":["Cinchocaine"],"drugbank":["DB00527"],"chEBI":["247956"]},"childChemblIds":["CHEMBL1200612"],"count":2,"approvedIndications":["HP_0000989","EFO_0009552"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000183873"],"count":2},"linkedDiseases":{"rows":["HP_0000989","EFO_0009552"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for hemorrhoid and pruritus."}
{"id":"CHEMBL109162","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1N","inchiKey":"MJMLUICFHWSBQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109162","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02268"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1181633","canonicalSmiles":"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccccc2)cc1","inchiKey":"VFCNQNZNPKRXIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILLIANT GREEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Brilliant_Green_(dye)"],"drugbank":["DB03895"],"chEBI":["44107"]},"childChemblIds":["CHEMBL1789985","CHEMBL3561225","CHEMBL186357","CHEMBL1545634"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1185242","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1","inchiKey":"XCCSSVMRGIQMGF-LPHOPBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1185242","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06994"]},"childChemblIds":["CHEMBL402163"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187011","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1","inchiKey":"YXUPZGKORWTXID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMIPHEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Domiphen"],"crossReferences":{"drugbank":["DB11594"]},"childChemblIds":["CHEMBL486696"],"count":1,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL1194666","canonicalSmiles":"CCN(CC)C(C)C(=O)c1ccccc1","inchiKey":"XXEPPPIWZFICOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLPROPION","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amfepramone","C06954","D07444","Diethylpropion","J4.327C"],"crossReferences":{"DailyMed":["diethylpropion%20hydrochloride"],"Wikipedia":["Amfepramone"],"drugbank":["DB00937"],"chEBI":["4530"]},"childChemblIds":["CHEMBL1693"],"count":1,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0000676","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for obesity."}
{"id":"CHEMBL1200396","canonicalSmiles":"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"SIEYLFHKZGLBNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1098","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupivac hcl","Bupivacaine hydrochloride","Bupivacaine hydrochloride kit","Bupivacaine hydrochloride preservative free","Marcain","Marcaine","Marcaine hydrochloride","Marcaine hydrochloride preservative free","Sensorcaine"],"synonyms":["AH-2250","Bupivacaine hydrochloride","Bupivacaine hydrochloride hydrate","Bupivacaine hydrochloride monohydrate","Bupivacaine hydrochloride rs","LAC-43","WIN 11,318","WIN-11318"],"crossReferences":{"DailyMed":["bupivacaine%20hydrochloride"],"PubChem":["26748842","56463371"],"chEBI":["31322"]},"count":8,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","HP_0030838","EFO_0003821","MONDO_0002959","MONDO_0007254","EFO_0000284","HP_0031217","MONDO_0002087","EFO_0003843","HP_0030016","EFO_0000311","EFO_0003964","EFO_0000546","EFO_0003931","EFO_0002506","HP_0003040","HP_0030834","EFO_0000764","EFO_0009552","HP_0001822","HP_0000023"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for pain and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200448","canonicalSmiles":"O=P([O-])(O)C(Sc1ccc(Cl)cc1)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"SKUHWSDHMJMHIW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"TILUDRONATE DISODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1350","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skelid"],"synonyms":["SR 41319B","SR-41319B","Tiludronate disodium"],"crossReferences":{"PubChem":["144206514"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL1200597","canonicalSmiles":"CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C.Cl","inchiKey":"LMWQQUMMGGIGJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDOCAINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL492","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duranest"],"synonyms":["Etidocaine HCl","Etidocaine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1200624","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ONKUMRGIYFNPJW-KIEAKMPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYNODIOL DIACETATE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femulen"],"synonyms":["Ethynodiol diacetate","Etynodiol","Etynodiol acetate","Etynodiol diacetate","SC 11800","SC-11800"],"crossReferences":{"DailyMed":["ethynodiol%20diacetate"],"PubChem":["144205886","144206477","170464933","29217896"],"drugbank":["DB00823"],"chEBI":["31580"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1200675","canonicalSmiles":"CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"IWEQQRMGNVVKQW-OQKDUQJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOREMIFENE CITRATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fareston"],"synonyms":["FC-1157A","NSC-613680","Toremifene citrate"],"crossReferences":{"DailyMed":["toremifene%20citrate"],"PubChem":["144205430","144212057","486747","49681796","50085986"]},"count":3,"approvedIndications":["EFO_0003869","MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003931","MONDO_0004658","MONDO_0007254","EFO_0003882","EFO_0000305"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200695","canonicalSmiles":"CC(N)C(O)c1ccccc1.Cl","inchiKey":"DYWNLSQWJMTVGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE HYDROCHLORIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL61006","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2002},"tradeNames":["Dexatrim","Dimotapp","Dimotapp l.a.","Eskornade","Procol","Propagest","Sine-off","Triogesic","Triominic"],"synonyms":["NSC-23798","Norephedrine hydrochloride","Phenylpropanolamine chloride","Phenylpropanolamine hydrochloride"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000120907"],"count":2},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958. It was withdrawn in United States  in 2002 due to Neurotoxicity."}
{"id":"CHEMBL1200701","canonicalSmiles":"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"SIGZQNJITOWQEF-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOXACILLIN SODIUM","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL893","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicloxacillin sodium","Dycill","Dynapen","Pathocil"],"synonyms":["BRL-1702","Dicloxacillin sodium","Dicloxacillin sodium hydrate","Dicloxacillin sodium monohydrate","Dicloxacillin sodium salt monohydrate","P-1011"],"crossReferences":{"DailyMed":["dicloxacillin%20sodium"],"PubChem":["144207044","170465296","56463521"],"chEBI":["52019"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1968 and has 1 investigational indication."}
{"id":"CHEMBL1200731","canonicalSmiles":"[Cl-].[K+]","inchiKey":"WCUXLLCKKVVCTQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"POTASSIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Diffu-k","Duro-k","K+10","K-contin","K-dur","K-dur 20","K-lease","K-tab","Kaleorid","Kaleorid lp","Kaon cl","Kaon cl-10","Kaon-Cl","Kato","Kay-cee-l","Klor-Con 10","Klor-Con 10Meq","Klor-Con 8","Klor-con","Klor-con m10","Klor-con m15","Klor-con m20","Kloref","Kloref-s","Klotrix","Leo k","Micro k","Micro-k","Micro-k 10","Micro-k ls","Nu-k","Pot chlor (pot 12mmol)","Pot chlor strong","Potassium chloride","Sando-k","Slow-k","Ten-k"],"synonyms":["B1653","E 508","E-508","E508","INS NO.508","INS-508","NSC-77368","Potassium chloride"],"crossReferences":{"DailyMed":["potassium%20chloride"],"DrugCentral":["4199"],"Wikipedia":["Potassium_chloride"],"drugbank":["DB00761"],"chEBI":["32588"]},"childChemblIds":["CHEMBL2105895"],"count":12,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 11 investigational indications. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200768","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)[O-].[Na+]","inchiKey":"JEEWDSDYUSEQML-ROMZVAKDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAZIDIME SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL44354","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftazidime sodium"],"crossReferences":{"chEBI":["53675"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200812","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"KSADBGVWHQJPAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL776","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alupent","Metaproterenol Sulfate","Prometa"],"synonyms":[],"crossReferences":{"PubChem":["26732609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200833","canonicalSmiles":"CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl","inchiKey":"VKFAUCPBMAGVRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPIVEFRIN HYDROCHLORIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201262","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akpro","Dipivefrin hydrochloride","Propine"],"synonyms":["Dipivefrin hydrochloride","Dipivefrine hydrochloride"],"crossReferences":{"PubChem":["144204226","56463529"],"chEBI":["4647"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201151","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C","inchiKey":"IMSSROKUHAOUJS-MJCUULBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESTRANOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["33355","EE3 ME","Mestranol"],"crossReferences":{"PubChem":["144204751","144212154","170465357","29215140","56422167","8139980"],"Wikipedia":["Mestranol"],"drugbank":["DB01357"],"chEBI":["6784"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL1201323","canonicalSmiles":"NCCc1cc[nH]n1","inchiKey":"JXDFEQONERDKSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAZOLE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betazole"],"crossReferences":{"PubChem":["11112911"],"Wikipedia":["Betazole"],"drugbank":["DB00272"],"chEBI":["59170"]},"childChemblIds":["CHEMBL1200949","CHEMBL4303510"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201373","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21","inchiKey":"QLJODMDSTUBWDW-BXMDZJJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVINOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mevinolinic acid"],"crossReferences":{"drugbank":["DB03785"],"chEBI":["82985"]},"childChemblIds":["CHEMBL487721","CHEMBL175236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201512","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"FOMIVIRSEN SODIUM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitravene","Vitravene preservative free"],"synonyms":["Fomivirsen eicosasodium salt","Fomivirsen sodium","ISIS 2922","ISIS-2922"],"count":2,"approvedIndications":["EFO_1001888"],"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for eye infection and has 1 investigational indication."}
{"id":"CHEMBL1201635","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE BEEF/PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph iletin i (beef-pork)"],"synonyms":["Insulin susp isophane beef/pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1201697","drugType":"Protein","blackBoxWarning":false,"name":"LH (MENOTROPINS)","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Human lh","Lh (menotropins)"],"count":1,"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0008560","EFO_0000660"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1975 and has 1 investigational indication."}
{"id":"CHEMBL1213135","canonicalSmiles":"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"YREISLCRUMOYAY-IIPCNOPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGONOVINE MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL119443","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ergotrate","Ergotrate maleate"],"synonyms":["Ergometrine maleate","Ergonovine maleate","NSC-93752"],"crossReferences":{"chEBI":["31554"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1213352","canonicalSmiles":"C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"MFZOSKPPVCIFMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pinazepam"],"crossReferences":{"Wikipedia":["Pinazepam"],"drugbank":["DB13335"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1213368","canonicalSmiles":"CCc1c(C)[nH]n(-c2nnn[nH]2)c1=O","inchiKey":"WAVWUEFMWJZZFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213368","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230044","canonicalSmiles":"N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C[C@H]1C(=O)N1CCCC1","inchiKey":"XDSKICAQKGYYJF-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07015"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230609","canonicalSmiles":"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1","inchiKey":"CXQHYVUVSFXTMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EXEL-2880","Foretinib","GSK-089","GSK-1363089","GSK-1363089G","GSK089","GSK1363089G","Gsk-1363089","XL-880","XL880"],"crossReferences":{"PubChem":["137275948"],"drugbank":["DB12307"]},"count":6,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000120156","ENSG00000105976","ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0000182","MONDO_0008903","MONDO_0007254","EFO_0005950","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1231347","canonicalSmiles":"CCCCSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O","inchiKey":"LTSUEVPGSXUJHT-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232397","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)NP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"XZLLMTSKYYYJLH-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232397","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01965"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235413","canonicalSmiles":"Cc1ccc(CCC(=O)O)cc1","inchiKey":"LDYGRLNSOKABMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235413","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237025","drugType":"Enzyme","blackBoxWarning":true,"name":"PEGLOTICASE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Krystexxa","Puricase"],"synonyms":["Pegloticase"],"crossReferences":{"DailyMed":["pegloticase"],"DrugCentral":["5176"],"Wikipedia":["Pegloticase"]},"count":2,"approvedIndications":["EFO_0004274"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for gout and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1254766","canonicalSmiles":"CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13","inchiKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRORPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextrorphan"],"crossReferences":{"drugbank":["DB14682"],"chEBI":["29133"]},"childChemblIds":["CHEMBL2106292","CHEMBL1426948","CHEMBL1256681"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256175","canonicalSmiles":"CC(=O)O.CNC(=N)NCCC[C@H](N)C(=O)O","inchiKey":"IKPNWIGTWUZCKM-JEDNCBNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILARGININE ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL256147","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANO-1020","Ng-methylarginine acetate","Tilarginine acetate"],"crossReferences":{"PubChem":["144204797","144207069","144207127","56463670"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1308","canonicalSmiles":"Cc1cn[nH]c1","inchiKey":"RIKMMFOAQPJVMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOMEPIZOLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antizol","Fomepizole"],"synonyms":["4-MP","4-methylpyrazole","Fomepizole"],"crossReferences":{"DailyMed":["fomepizole"],"PubChem":["11111426","50111124","90341211"],"Wikipedia":["Fomepizole"],"drugbank":["DB01213"],"chEBI":["5141"]},"childChemblIds":["CHEMBL1256285"],"count":1,"linkedTargets":{"rows":["ENSG00000187758","ENSG00000248144","ENSG00000196616"],"count":3},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
{"id":"CHEMBL13209","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1","inchiKey":"KJONHKAYOJNZEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mogadon","Nitrados","Remnos","Somnite","Unisomnia"],"synonyms":["N05CD02","NSC-58775","Nitrazepam","RO 4-5360","RO 5-3059","RO-4-5360","RO-45360","RO-5-3059","RO-53059"],"crossReferences":{"PubChem":["144205154","170465667","29215277","50086824"],"Wikipedia":["Nitrazepam"],"drugbank":["DB01595"],"chEBI":["7581"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL132722","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"CAWZRIXWFRFUQB-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha,beta-MeATP"],"crossReferences":{"PubChem":["26756671","90341608"],"drugbank":["DB02596"],"chEBI":["35056"]},"childChemblIds":["CHEMBL1257023"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1334860","canonicalSmiles":"CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1","inchiKey":"BDYYDXJSHYEDGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILOXANIDE FUROATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entamizole","Furamide"],"synonyms":["Diloxanide furoate"],"crossReferences":{"PubChem":["11112544","144207041","170466783","56422440","855852"],"Wikipedia":["Diloxanide_furoate"],"drugbank":["DB14638"],"chEBI":["4601"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL133809","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1N","inchiKey":"CQKMBZHLOYVGHW-QYYRPYCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL133809","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL136800","canonicalSmiles":"O=C(c1ccc2nccnc2c1)N1CCCCC1","inchiKey":"ANDGGVOPIJEHOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CX516","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BDP 12","BDP-12","CX 516","CX-516","Cx516"],"crossReferences":{"Wikipedia":["CX-516"],"drugbank":["DB06247"],"chEBI":["34605"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1418195","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O.O","inchiKey":"SDJQUPRVYCURBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1418195","maximumClinicalTrialPhase":0,"parentId":"CHEMBL527","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26719733"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL146428","canonicalSmiles":"N=C1NC(=O)N2CC12","inchiKey":"BIXBBIPTYBJTRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMEXON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Amplimexon"],"synonyms":["Imexon","NSC-313425"],"crossReferences":{"PubChem":["144206332","455679","50125901","92763386"],"drugbank":["DB05003"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1466","canonicalSmiles":"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O","inchiKey":"DOBMPNYZJYQDGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICUMAROL","yearOfFirstApproval":1944,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicumarol"],"synonyms":["Bishydroxycoumarin","Dicoumarol","Dicumarol"],"crossReferences":{"PubChem":["11112184","144203908","170465275"],"Wikipedia":["Dicoumarol"],"drugbank":["DB00266"],"chEBI":["4513"]},"count":1,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0004419"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1944 and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL1542","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12","inchiKey":"LMEKQMALGUDUQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AZATHIOPRINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azamune","Azapress","Azasan","Azathioprine","Berkaprine","Immunoprin 50","Imuran","Kentaprine","Oprisine 50"],"synonyms":["Azathioprine","BW-57-322","NSC-39084"],"crossReferences":{"DailyMed":["azathioprine","azathioprine%20sodium"],"PubChem":["104171105","11110740","11110741","124879189","144203625","144213985","170464989","17390031","174006316","26670994","26747870","26747871","26747872","26752814","50105466","50105467","50105468","85230906","90340846"],"TG-GATEs":["46"],"Wikipedia":["Azathioprine"],"drugbank":["DB00993"],"chEBI":["2948"]},"childChemblIds":["CHEMBL1200400","CHEMBL3785814","CHEMBL3785780"],"count":35,"approvedIndications":["EFO_0000685","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","Orphanet_232","EFO_0000318","EFO_0004274","EFO_0000768","EFO_0000540","EFO_0006803","EFO_0005676","EFO_0007160","EFO_0005531","EFO_0002690","MONDO_0002898","EFO_0003884","EFO_0000182","EFO_0004244","EFO_0007208","EFO_0004826","EFO_0004991","EFO_1000749","EFO_0004719","EFO_0000198","EFO_0000685","EFO_0005761","EFO_0000545","EFO_0009012","EFO_1001857","Orphanet_79213","HP_0000964","EFO_0000222","EFO_0004194","EFO_0003818","EFO_0000384","EFO_1000784","EFO_0004599","EFO_0009448","HP_0001873","EFO_0007187","EFO_0005297","EFO_0004256","EFO_0003767"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for rheumatoid arthritis and immune system disease and has 33 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1555","canonicalSmiles":"Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2","inchiKey":"QORVDGQLPPAFRS-XPSHAMGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALANTAMINE HYDROBROMIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL659","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galantamine hydrobromide","Razadyne","Razadyne er"],"synonyms":["Galantamine hydrobromide"],"crossReferences":{"DailyMed":["galantamine%20hydrobromide"],"PubChem":["26719770","49681569"]},"count":5,"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["Orphanet_282","HP_0100543","EFO_0004718","HP_0000726","EFO_0000249","EFO_0000677","EFO_0000692"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 5 investigational indications."}
{"id":"CHEMBL15562","canonicalSmiles":"c1cncnc1","inchiKey":"CZPWVGJYEJSRLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-89305","Pyrimidine"],"crossReferences":{"Wikipedia":["Pyrimidine"],"chEBI":["16898"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL156025","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"PSWFFKRAVBDQEG-YGQNSOCVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"THYMOPENTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORF 15244","ORF-15244","TP-5","Thymopentin","Thymopoietin 32-36"],"crossReferences":{"PubChem":["144205973"],"Wikipedia":["Thymopentin"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL157366","canonicalSmiles":"CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)OC(COC(C)=O)COC(=O)CCCCCCCCCCCCCCC","inchiKey":"GAKUNXBDVGLOFS-DUZKARGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSEDIPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-18","Ec-18","Mosedipimod"],"crossReferences":{"drugbank":["DB12592"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1628650","canonicalSmiles":"[3H]c1cc2c(cc1OC[C@@H]1CNCC[C@H]1c1ccc(F)cc1)OCO2","inchiKey":"AHOUBRCZNHFOSL-RXMHWKDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]PAROXETINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL490","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[3H]-Paroxetine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697854","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/NC(=O)c1ccccc1)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"FBTUMDXHSRTGRV-ALTNURHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZORUBICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zorubicin"],"childChemblIds":["CHEMBL2105778"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1728","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.Cl","inchiKey":"KXEBLAPZMOQCKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMEFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL561","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxaquin"],"synonyms":["Lomefloxacin hydrochloride","Lomefloxacin monohydrochloride","NY-198","SC-47111"],"crossReferences":{"PubChem":["144204267","144206705","170465262","26747546","50106492"],"chEBI":["6518"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL1743042","drugType":"Antibody","blackBoxWarning":false,"name":"MOTAVIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Numax"],"synonyms":["MEDI-524","Motavizumab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743052","drugType":"Antibody","blackBoxWarning":false,"name":"OPORTUZUMAB MONATOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Proxinium","Proxinium, Vicinium","Vicinium"],"synonyms":["Oportuzumab monatox","VB4-845"],"count":3,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000294","MONDO_0001187"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743080","drugType":"Antibody","blackBoxWarning":false,"name":"TIGATUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-1008","TRA-8","Tigatuzumab"],"count":6,"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","MONDO_0008170","EFO_0000182","EFO_0004142","EFO_0000574","EFO_0003060"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL17432","canonicalSmiles":"O=c1[nH]c(=O)n(COCCO)cc1Cc1ccccc1","inchiKey":"SPJAGILXQBHHSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL17432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07437"],"chEBI":["41037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL175247","canonicalSmiles":"CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O","inchiKey":"AHLBNYSZXLDEJQ-FWEHEUNISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORLISTAT","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alli","Beacita","Xenical"],"synonyms":["Lipstatin","Orlipastat","Orlistat","RO 18-0647/002","RO-180647-002","RO-180647002","Tetrahydrolipstatin"],"crossReferences":{"DailyMed":["orlistat"],"PubChem":["26719846","29217614","49681644","93576635"],"Wikipedia":["Orlistat"],"drugbank":["DB01083"]},"count":5,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000175535","ENSG00000182333"],"count":2},"linkedDiseases":{"rows":["HP_0012115","EFO_0000195","HP_0001397","EFO_0000545","Orphanet_411","EFO_0001360","EFO_0001073","EFO_0000660"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for obesity and has 4 investigational indications."}
{"id":"CHEMBL1757","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)(O)O","inchiKey":"YMDXZJFXQJVXBF-STHAYSLISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosfocina"],"synonyms":["Fosfomycin","Fosfomycin calcium","Fosfomycin sodium","J01XX01","Monurol","ZTI-01","Zti-01"],"crossReferences":{"DailyMed":["fosfomycin%20tromethamine"],"Wikipedia":["Fosfomycin"],"drugbank":["DB00828"],"chEBI":["28915"]},"childChemblIds":["CHEMBL2322189","CHEMBL3188549","CHEMBL1200331","CHEMBL4576729","CHEMBL1256140"],"count":12,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for bacterial disease and has 11 investigational indications."}
{"id":"CHEMBL1769","canonicalSmiles":"CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC.Cl","inchiKey":"GITPCGSPKUQZTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOXYCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1195","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blockain hydrochloride","Ravocaine hydrochloride"],"synonyms":["Propoxycaine HCl","Propoxycaine hydrochloride"],"crossReferences":{"PubChem":["144204013","56463554"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1773","canonicalSmiles":"CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F","inchiKey":"GAGWJHPBXLXJQN-UORFTKCHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CAPECITABINE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","RO 09-1978/000","RO-09-1978000","RO-091978000","Xeloda"],"crossReferences":{"DailyMed":["capecitabine"],"PubChem":["144205751","170464779"],"Wikipedia":["Capecitabine"],"drugbank":["DB01101"],"chEBI":["31348"]},"count":73,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","MONDO_0021063","EFO_0000305","EFO_0004288","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0005543","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1000984","EFO_1001951","EFO_0000178","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0000182","MONDO_0005411","EFO_0008528","MONDO_0003659","EFO_0004288","EFO_1000045","EFO_1001949","EFO_0002618","EFO_0005922","MONDO_0021321","MONDO_0002108","MONDO_0008170","EFO_0005842","EFO_0005221","MONDO_0008315","MONDO_0001879","EFO_0009708","MONDO_0002691","MONDO_0015917","MONDO_0002165","MONDO_0044787","EFO_0005537","EFO_0004284","EFO_0008490","MONDO_0021640","EFO_0002938","EFO_1001901","EFO_0007416","MONDO_0007254","EFO_0004252","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0044937","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_1000218","EFO_0003860","EFO_0006352","MONDO_0001657","EFO_0000326","EFO_1001893","EFO_0000707","EFO_0005588","EFO_1000158","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0005774","EFO_0002916","EFO_0000503","EFO_0000478","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_1001471","EFO_0003865","MONDO_0002120","EFO_0006861","EFO_0002517","EFO_0004142","MONDO_0002367","MONDO_0003219","EFO_1000081","MONDO_0024880","EFO_0000181","EFO_0000519","MONDO_0044926"],"count":88},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 7 approved and 66 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1788384","canonicalSmiles":"CC(=O)Nc1cc([As]2SCC(CO)S2)ccc1O","inchiKey":"MRUDSZSRLQAPOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSTHINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arsthinenol","Arsthinol","Mercaptoarsenical","Mercaptoarsenol"],"crossReferences":{"drugbank":["DB08928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL181954","canonicalSmiles":"CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O","inchiKey":"OKJHGOPITGTTIM-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVEGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-519818","LY-9818","LY519818","LY9818","Ly519818","Naveglitazar"],"crossReferences":{"drugbank":["DB12662"]},"count":1,"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL186174","canonicalSmiles":"Clc1ccc(CN(Cc2ccc(Cl)cc2)c2nn[nH]n2)cc1","inchiKey":"UOUXILZUBDIWQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL186174","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817477"],"drugbank":["DB04037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186314","canonicalSmiles":"O=C([O-])[O-].[Na+].[Na+]","inchiKey":"CDBYLPFSWZWCQE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CARBONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E500","Sodium carbonate"],"crossReferences":{"DrugCentral":["5132"],"Wikipedia":["Sodium_carbonate"],"drugbank":["DB09460"],"chEBI":["29377"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1863514","drugType":"Enzyme","blackBoxWarning":false,"name":"ASPARAGINASE ERWINIA CHRYSANTHEMI","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erwinase[r] erwinaze[tm]","Erwinaze"],"synonyms":["Asparaginase erwinia chrysanthemi","crisantaspase (INN)"],"crossReferences":{"DailyMed":["asparaginase%20erwinia%20chrysanthemi"]},"count":5,"approvedIndications":["MONDO_0000873","EFO_0000220"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for acute lymphoblastic leukemia and lymphoblastic lymphoma and has 3 investigational indications."}
{"id":"CHEMBL1961796","canonicalSmiles":"CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1","inchiKey":"MMJJNHOIVCGAAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR9009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1997417","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)n1.Cl","inchiKey":"GPDAJAWUGSTOSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1094966","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144203612","576338"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096633","canonicalSmiles":"O=[Si]([O-])O[Si]([O-])([O-])O[Si](=O)[O-].[Mg+2].[Mg+2]","inchiKey":"GXGAKHNRMVGRPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM TRISILICATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2109882","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mag trisil co","Trimax"],"synonyms":["Magnesium silicates magnesium trisilicate","Magnesium trisilicate"],"crossReferences":{"drugbank":["DB09281"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL2103877","canonicalSmiles":"C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1","inchiKey":"NFEZZTICAUWDHU-RDTXWAMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFINACONAZOLE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jublia"],"synonyms":["Efinaconazole","IDP-108","KP-103"],"crossReferences":{"DailyMed":["efinaconazole"],"drugbank":["DB09040"],"chEBI":["82718"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL2104045","canonicalSmiles":"CCOCCOC(=O)/C=C/c1ccc(OC)cc1","inchiKey":"CMDKPGRTAQVGFQ-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOXATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cinoxate"],"crossReferences":{"drugbank":["DB15467"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2104234","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCOCc2ccccc2)CC1","inchiKey":"UVTBZAWTRVBTMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZETHIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzethidine","NIH 7574"],"crossReferences":{"drugbank":["DB01518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105040","canonicalSmiles":"CNCC(O)c1cc(OC)c(O)c(OC)c1","inchiKey":"ZKGDBJAHIIXDDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETOFRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimetofrine"],"crossReferences":{"drugbank":["DB13494"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105131","canonicalSmiles":"CN(CC1(C)CCCO1)S(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"SMNOERSLNYGGOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEFRUSIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baycaron"],"synonyms":["BAY 1500","Mefruside"],"crossReferences":{"PubChem":["144206878"],"drugbank":["DB13405"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL2105680","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c([O-])c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.[Na+]","inchiKey":"YVOFSHPIJOYKSH-NLYBMVFSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAMYCIN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL437765","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aemcolo"],"synonyms":["CB-01-11","RIFAMYCIN SV","Rifamycin","Rifamycin sodium"],"crossReferences":{"DailyMed":["rifamycin%20sodium"],"PubChem":["144205617","144210004"]},"count":1,"approvedIndications":["HP_0002014"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for diarrhea."}
{"id":"CHEMBL2105862","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2.Cl","inchiKey":"LIODALMQEWEPTB-OWIKXPBHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ISEGANAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IB-367-03","Iseganan hydrochloride","Iseganan hydrochloride hydrate"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105894","canonicalSmiles":"O=C([O-])[O-].[K+].[K+]","inchiKey":"BWHMMNNQKKPAPP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASH, SULFURATED","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106167","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)CN(C1CCCCC1)C2=O","inchiKey":"VPMWFZKOWULPGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOREXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorexolone"],"crossReferences":{"PubChem":["170466039"],"drugbank":["DB13617"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106941","canonicalSmiles":"CC(C)(C)C(=O)NNCc1ccccc1","inchiKey":"FWWDFDMCZLOXQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIVHYDRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pivhydrazine"],"crossReferences":{"drugbank":["DB09252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107315","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C.Cl","inchiKey":"SJKBXKKZBKCHET-UQIIZPHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELOTECAN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111084","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belotecan hydrochloride","CKD-602"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107331","canonicalSmiles":"CC[C@H]1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21","inchiKey":"RUJBDQSFYCKFAA-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTOFISOPAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextofisopam","R-TOFISOPAM"],"crossReferences":{"drugbank":["DB06582"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107342","canonicalSmiles":"CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]1C","inchiKey":"VWAMTBXLZPEDQO-UZSBJOJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMITHROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gamithromycin","ML-1,709,460"],"crossReferences":{"drugbank":["DB11416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108251","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ANTICOAGULANT HEPARIN SOLUTION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anticoagulant heparin solution"],"count":3,"description":"Oligosaccharide drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108429","drugType":"Antibody","blackBoxWarning":false,"name":"MEPOLIZUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bosatria","Nucala"],"synonyms":["Mepolizumab","SB-240563"],"crossReferences":{"DailyMed":["mepolizumab"],"DrugCentral":["5061"]},"count":10,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000113525"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","HP_0006536","EFO_0005531","EFO_1000391","EFO_0000270","EFO_0007208","EFO_0000341","EFO_0000274","EFO_1001467","HP_0001880"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for asthma and airway obstruction and has 8 investigational indications."}
{"id":"CHEMBL2108575","drugType":"Antibody","blackBoxWarning":false,"name":"ASELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aselizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108738","drugType":"Antibody","blackBoxWarning":false,"name":"NIVOLUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"crossReferences":{"DailyMed":["nivolumab"],"DrugCentral":["4923"]},"count":120,"approvedIndications":["EFO_0000616","EFO_0000756","EFO_0000389","EFO_0003060","EFO_0002617","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0003891","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0005952","EFO_0007304","MONDO_0044704","EFO_1000984","EFO_0000632","EFO_1001951","MONDO_0001416","MONDO_0015760","EFO_0000339","EFO_0000564","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0000514","MONDO_0003659","Orphanet_2495","MONDO_0002038","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","MONDO_0019465","EFO_0001642","EFO_1001512","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_1000026","MONDO_0002691","MONDO_0002547","MONDO_0000544","EFO_0000335","EFO_0008524","EFO_0004284","EFO_0000574","EFO_0001378","EFO_1000796","EFO_0000292","EFO_1001972","MONDO_0045069","EFO_1001465","MONDO_0007254","EFO_0004252","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","Orphanet_377","EFO_0003968","EFO_1001974","EFO_0000196","EFO_0000326","EFO_0000183","EFO_0004193","EFO_0000707","EFO_0000616","EFO_0006859","EFO_1000603","EFO_0002916","MONDO_0024503","EFO_1000314","EFO_0000403","Orphanet_44890","MONDO_0007576","EFO_0000222","MONDO_0000870","EFO_0000304","EFO_1001471","MONDO_0002120","EFO_0002517","EFO_0000702","EFO_0000199","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_1001927","EFO_0000519","MONDO_0003060","HP_0002745","EFO_0005543","EFO_0001075","EFO_0000571","EFO_1000575","MONDO_0045056","EFO_1000657","EFO_0000228","EFO_0000565","Orphanet_178","MONDO_0017582","EFO_0009709","EFO_0000389","EFO_0000182","MONDO_0020634","EFO_0007541","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","MONDO_0004669","EFO_1000157","MONDO_0044881","EFO_0004239","EFO_1000344","MONDO_0015917","HP_0100806","EFO_0001061","MONDO_0100096","EFO_0005537","EFO_0006544","EFO_1000613","EFO_1001051","EFO_0000563","MONDO_0009348","MONDO_0015686","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_0000708","EFO_0000305","EFO_0003085","MONDO_0020657","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_0007466","EFO_0000770","MONDO_0001657","EFO_0000673","MONDO_0020743","EFO_0002617","EFO_1000616","EFO_0000478","EFO_1000508","EFO_0000313","EFO_0004243","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0000640","EFO_0003863","EFO_0000095","EFO_0002892","EFO_0004142","MONDO_0003219","EFO_1000081","EFO_0003050","EFO_0000691","EFO_0000181","EFO_0003833","MONDO_0021637","EFO_1001950"],"count":161},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 6 approved and 114 investigational indications."}
{"id":"CHEMBL2109356","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-022","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-022","Biib 022","Biib-022"],"count":3,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0003060"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109438","drugType":"Antibody","blackBoxWarning":false,"name":"MBL-HCV-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBL-HCV-1","Mbl-hcv-1"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109540","drugType":"Antibody","blackBoxWarning":false,"name":"ALIROCUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Praluent"],"synonyms":["Alirocumab","REGN-727","REGN727","SAR-236553","SAR236553"],"crossReferences":{"DailyMed":["alirocumab"],"DrugCentral":["5016"]},"count":7,"approvedIndications":["Orphanet_391665","EFO_0000319","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","MP_0001845","HP_0003124","EFO_0001645","Orphanet_391665","EFO_0000319","EFO_0000400","EFO_0004911","Orphanet_309005","EFO_0004265"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL2110978","canonicalSmiles":"O=S(=O)(O)CI","inchiKey":"RDFJFVXMRYVOAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIODAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methiodal"],"crossReferences":{"drugbank":["DB13321"]},"childChemblIds":["CHEMBL2106907"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146121","canonicalSmiles":"[CaH2]","inchiKey":"FAQLAUHZSGTTLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcium"],"count":39,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 39 investigational indications."}
{"id":"CHEMBL215645","canonicalSmiles":"CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"GWHQHAUAXRMMOT-MERQFXBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVASTIGMINE TARTRATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL636","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exelon","Rivastigmine tartrate"],"synonyms":["ENA 713","Rivastigmine Tartrate","Rivastigmine hydrogen tartrate","Rivastigmine tartrate"],"crossReferences":{"DailyMed":["rivastigmine%20tartrate"]},"count":3,"approvedIndications":["EFO_0002508","HP_0000726"],"linkedTargets":{"rows":["ENSG00000087085","ENSG00000114200"],"count":2},"linkedDiseases":{"rows":["EFO_0002508","HP_0000726","EFO_0005252"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for dementia and parkinson's disease and has 1 investigational indication."}
{"id":"CHEMBL2252704","canonicalSmiles":"C[C@H]1CC=CC(=O)O1","inchiKey":"DYNKRGCMLGUEMN-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-(6S)-PARASORBIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14121"],"chEBI":["7926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227123","canonicalSmiles":"NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12","inchiKey":"JLSKPBDKNIXMBS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trp-NH2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trp-NH2"],"crossReferences":{"drugbank":["DB04537"],"chEBI":["16533"]},"childChemblIds":["CHEMBL1222006"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251940","canonicalSmiles":"N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2","inchiKey":"LUALIOATIOESLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERICIAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neulactil"],"synonyms":["Periciazine","Pericyazine","Propericiazine","RP 8909","SKF 20716"],"crossReferences":{"PubChem":["144204970","26748871"],"drugbank":["DB01608"],"chEBI":["31981"]},"count":1,"approvedIndications":["EFO_0005407"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL266125","canonicalSmiles":"Cc1ccc2cc(C(=O)NC3(C(=O)N[C@H](Cc4ccccc4)C(=O)NCC4CCN(CC5CCOCC5)CC4)CCCC3)sc2c1","inchiKey":"YQYSVMKCMIUCHY-WJOKGBTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBODUTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibodutant","Men15596"],"crossReferences":{"drugbank":["DB12042"]},"count":1,"linkedTargets":{"rows":["ENSG00000075073"],"count":1},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL270875","canonicalSmiles":"NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"APYXQTXFRIDSGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07457"],"chEBI":["41059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274047","canonicalSmiles":"O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1","inchiKey":"CEIJFEGBUDEYSX-FZDBZEDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDOSPIRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tandospirone"],"crossReferences":{"PubChem":["144206869"],"Wikipedia":["Tandospirone"],"drugbank":["DB12833"]},"childChemblIds":["CHEMBL1628275","CHEMBL2103888"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279956","canonicalSmiles":"N[C@@H](Cn1oc(=O)[nH]c1=O)C(=O)O","inchiKey":"ASNFTDCKZKHJSW-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUISQUALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quisqualate","quisqualic acid"],"crossReferences":{"PubChem":["11113399","26751639","47193871","50104331","90341112"],"Wikipedia":["Quisqualic_acid"],"drugbank":["DB02999"],"chEBI":["8734"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282724","canonicalSmiles":"Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2","inchiKey":"PHWXUGHIIBDVKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAXENTAN","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Hepatotoxicity"],"year":2010},"tradeNames":[],"synonyms":["IPI-1040","Sitaxentan","Sitaxsentan","TBC-11251"],"crossReferences":{"PubChem":["170465720"],"Wikipedia":["Sitaxentan"],"drugbank":["DB06268"]},"childChemblIds":["CHEMBL2105740"],"count":7,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","HP_0000093","EFO_0000270","EFO_0003884","EFO_0000537","EFO_1000899"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for hypertension and has 6 investigational indications. It was withdrawn in European Union  in 2010 due to Hepatotoxicity."}
{"id":"CHEMBL290140","canonicalSmiles":"CNC(=O)[C@H](Cc1c(F)c(F)c(F)c(F)c1F)NC(=O)Nc1nnc(S)s1","inchiKey":"HZAXNPDJVFUGDS-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-142372","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-142372"],"crossReferences":{"drugbank":["DB07988"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292821","canonicalSmiles":"COc1cc(CCN)c(OC)cc1Br","inchiKey":"YMHOBZXQZVXHBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL292821","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2C-B"],"drugbank":["DB01537"],"chEBI":["189669"]},"childChemblIds":["CHEMBL2362607"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295433","canonicalSmiles":"C[C@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1","inchiKey":"QIPQASLPWJVQMH-DTORHVGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORBIFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orbax"],"synonyms":["Orbifloxacin"],"crossReferences":{"PubChem":["144205420","170465644","29216200","29216201","49647788"],"Wikipedia":["Orbifloxacin"],"drugbank":["DB11443"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297302","canonicalSmiles":"O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1","inchiKey":"FEBOTPHFXYHVPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENPERIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anquil","Benquil"],"synonyms":["Benperidol","MCN-JR-4584","NSC-170982","R-4584"],"crossReferences":{"PubChem":["11112508","144204068","170466409","56463215"],"Wikipedia":["Benperidol"],"drugbank":["DB12867"]},"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0000692","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL298019","canonicalSmiles":"CCOC(=O)c1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1","inchiKey":"KCHIOGFOPPOUJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRODAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirodavir","R 77975"],"crossReferences":{"drugbank":["DB08012"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL299400","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3","inchiKey":"GMTYREVWZXJPLF-SXWPHCFWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUTORPHANOL TARTRATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL33986","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butorphanol tartrate","Butorphanol tartrate preservative free","Stadol","Stadol ns","Stadol preservative free","Torbugesic","Torbutrol"],"synonyms":["Butorphanol tartrate","Butorphanol tartrate civ","LEVO-BC-2627 TARTRATE"],"crossReferences":{"DailyMed":["butorphanol%20tartrate"]},"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3039556","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APATORSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apatorsen","OGX-427"],"count":6,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL307177","canonicalSmiles":"O=C(Nc1ccc(Cl)c(Cl)c1)NS(=O)(=O)c1ccc2c(c1)CCO2","inchiKey":"VAMFSFIPDOODFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-295501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ILX-295501","Ilx-295501","LY-295501","LY295501","Ly-295501"],"crossReferences":{"drugbank":["DB12574"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301580","drugType":"Antibody","blackBoxWarning":false,"name":"FLETIKUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-IL-20","Fletikumab","NNC-0109-0012","NNC01 09-0012","NNC0109-0012"],"count":3,"linkedTargets":{"rows":["ENSG00000162891"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000685","EFO_0000676"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3306853","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](c3ccccc3)S(=O)(=O)O)C(=O)N2[C@H]1C(=O)O","inchiKey":"JETQIUPBHQNHNZ-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3306853","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13693"]},"childChemblIds":["CHEMBL4303686","CHEMBL3185827"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544915","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)[O-].[Na+]","inchiKey":"JYIOGGWFNHGWMN-CWNXUBRBSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FALDAPREVIR SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1241348","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 201335 NA","Faldaprevir sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544936","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-844","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xl-844"],"count":2,"linkedTargets":{"rows":["ENSG00000183765","ENSG00000149554"],"count":2},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000574"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544939","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2979165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HY-13239","Ly2979165"],"count":1,"linkedTargets":{"rows":["ENSG00000164082"],"count":1},"linkedDiseases":{"rows":["EFO_0000289"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545049","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1125976","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1125976","Bay-1125976"],"count":1,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000142208"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545122","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](CC(C)C)C(=O)O)CSSC[C@@H](C(=O)N[C@H](C(=O)O)C(C)C)NC1=O","inchiKey":"WGEWYYPHYMGJNT-HLHYUOOASA-N","drugType":"Protein","blackBoxWarning":false,"name":"DOLCANATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dolcanatide","SP-333"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545167","drugType":"Protein","blackBoxWarning":false,"name":"FE 202767","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fe 202767"],"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3623290","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C","inchiKey":"MXDSJQHFFDGFDK-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3759","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD3759","Azd 3759","Azd-3759","Azd3759","Zorifertinib"],"crossReferences":{"drugbank":["DB14795"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3633460","canonicalSmiles":"COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O","inchiKey":"ICYNYWFGIDGBRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06282999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06282999"],"crossReferences":{"drugbank":["DB11683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL368591","canonicalSmiles":"CCC(O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"QIRAYNIFEOXSPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEPHEPTANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amidol","Bimethadol","Dimepheptanol","IDS-ND-012","Methadol","NIH 2933","NIH-2933","Racemethadol"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL370437","canonicalSmiles":"O=C(O)c1ccc(-c2cc(Cl)ccc2Cl)o1","inchiKey":"ATAZLMGGQQLRBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL370437","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07758"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707232","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS SUCCINATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferromyn"],"synonyms":["CEREVON","Ferrous succinate"],"crossReferences":{"DrugCentral":["4544"]},"count":1,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL3716552","canonicalSmiles":"COc1cc(OCc2csc(-c3ccc(C(=O)N(C)C)cc3)n2)c2cc(-c3cn4nc(OC)sc4n3)oc2c1","inchiKey":"KEEBLYWBELVGPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986141","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986141","Bms-986141","UDM-003183"],"crossReferences":{"drugbank":["DB14942"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL372205","canonicalSmiles":"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1","inchiKey":"NRPQELCNMADTOZ-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LECOZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lecozotan"],"crossReferences":{"drugbank":["DB12540"]},"childChemblIds":["CHEMBL2107349"],"count":1,"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL37858","canonicalSmiles":"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"XBHBWNFJWIASRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARAFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sarafloxacin"],"crossReferences":{"PubChem":["174006988"],"Wikipedia":["Sarafloxacin"],"drugbank":["DB11491"]},"childChemblIds":["CHEMBL1730031","CHEMBL542157"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379760","canonicalSmiles":"COc1ccc(N(C(=O)Nc2ccccc2Cl)c2ccnc(N[C@@H](C)C(C)(C)O)n2)cc1","inchiKey":"ZWYFTKPEHRQCCW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379760","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833348","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBNITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mammol"],"synonyms":["Bismuth subnitrate"],"crossReferences":{"DrugCentral":["4841"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL383541","canonicalSmiles":"N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12","inchiKey":"SGHXFHRRWFLILP-XJDXJNMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383541","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07107"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL383675","canonicalSmiles":"Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc2CC4)C=C3)c1","inchiKey":"KSXLETNRCMCRAQ-LWQDQPMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOPORFIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Foscan"],"synonyms":["EF-9","EF9","Mthpc","Temoporfin"],"count":8,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 7 investigational indications."}
{"id":"CHEMBL389621","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"JYGXADMDTFJGBT-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetasol hc","Acticort","Aeroseb-hc","Ala-cort","Ala-scalp","Alphaderm","Anflam","Anucort-Hc","Anugesic hc","Anusol hc","Anusol plus hc","Anusol soothing relief","Anusol-Hc","Balneol-hc","Beta-hc","Calmurid hc","Canesten hc","Cetacort","Cipro hc","Cobadex","Colocort","Corlan","Cort-dome","Cortef","Cortenem","Cortenema","Cortril","Daktacort","Daktacort hydrocort","Derma care hydrocort","Dermacort","Dermaspray demang","Dioderm","Dome-cort","Econacort","Efcortelan p","Eldecort","Epicort","Eurax-hc","Eurax-hydrocort","Evacort","Exe-cort","Flexicort","Germoloids hc","Glycort","Gregoderm","H-cort","Hc #1","Hc #4","Hc (hydrocortisone)","Hi-cor","Hydro-rx","Hydrocort in calamine oily","Hydrocort in cetomacrogol for a","Hydrocort in wte soft paraf","Hydrocortisone","Hydrocortisone in absorbase","Hydrocortone","Hydroderm","Hydroderm hc","Hytone","Jungle for","Locoid","Medicort","Mildison lipocream","Nogenic hc","Nutracort","Nybadex","Nystaform-hc","Otoseptil","Otosporin","Penecort","Perinal","Plenadren","Proctocort","Proctocream hc","Proctofoam hc","Proctosedyl","Quinocort","Sential hc","Stie-cort","Synacort","Terra-cortril nystatin","Texacort","Timocort","Timodine","Topisone","Tri-cicatrin","Uniroid","Uniroid hc","Xyloproct","Zenoxone"],"synonyms":["Cor-Oticin","Cortifoam","Cortisol","FLEXICORT","Hydrocortisone","Micort-HC","NSC-10483","Neo-Cortef","Ophthocort","Terra-Cortril","U-Cort"],"crossReferences":{"DailyMed":["hydrocortisone"],"PubChem":["144204434","144208013","170464635","26751519","26751520","29215010","56422453","75748","85148352","855803","90341326"],"Wikipedia":["Cortisol"],"drugbank":["DB00741"],"chEBI":["17650"]},"count":80,"approvedIndications":["EFO_0003106","EFO_0000729","MP_0001845","EFO_1001347","EFO_0002506","EFO_0009560","EFO_0000270","EFO_0009552","EFO_0000274","HP_0001742","EFO_0000384","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0003811","EFO_0005539","EFO_0000729","MONDO_0000873","EFO_1001104","EFO_0000275","EFO_0000756","EFO_0003768","HP_0004798","EFO_0003829","EFO_0000565","EFO_0004251","EFO_1001347","EFO_0002506","EFO_0009560","EFO_0000544","MONDO_0019460","EFO_0000330","MONDO_0015540","EFO_0009552","EFO_0007541","EFO_0000198","EFO_0003802","EFO_0000221","HP_0012076","EFO_0000220","HP_0000964","EFO_1001908","EFO_0000223","EFO_0009516","EFO_1001946","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0003025","Orphanet_418","HP_0100806","EFO_0001422","MP_0001845","EFO_0000546","GO_0007568","MONDO_0100096","EFO_0003032","EFO_0004192","Orphanet_90794","EFO_0000270","EFO_0001359","HP_0003074","MONDO_0002406","EFO_0000574","EFO_0007328","EFO_0001378","EFO_0000218","EFO_1000796","HP_0031273","EFO_0005251","EFO_0005687","EFO_0003812","EFO_0006834","EFO_1001494","EFO_1001945","EFO_0000274","EFO_0000209","EFO_1000637","MONDO_0003541","EFO_1000044","EFO_0009444","EFO_1001216","Orphanet_70589","EFO_0003860","EFO_0003144","EFO_0000673","MONDO_0020743","EFO_0005752","EFO_1000158","MONDO_0009410","EFO_0000616","EFO_1001779","MONDO_0015128","MONDO_0026045","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0001358","EFO_0010702","EFO_0001073","HP_0002315","EFO_0003106","EFO_0001072","MONDO_0021340","EFO_0002614","EFO_0000764","EFO_1001818","EFO_0007359","EFO_1001947","EFO_0007141","EFO_0005611","EFO_0000612","EFO_0009492","EFO_0003027","EFO_0007543"],"count":101},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 12 approved and 68 investigational indications."}
{"id":"CHEMBL3989481","canonicalSmiles":"C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"GTPHQORJKFJIRB-JTQLPTLWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FRAKEFAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bch-3963","Frakefamide","LEF-576","SPD759"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989589","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.O=S(=O)(O)O","inchiKey":"BNPSSFBOAGDEEL-NMFAMCKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALBUTEROL SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1002","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levalbuterol sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989958","canonicalSmiles":"N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1","inchiKey":"WIJZXSAJMHAVGX-DHLKQENFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IVOSIDENIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tibsovo"],"synonyms":["AG-120","Ivosidenib"],"crossReferences":{"DailyMed":["ivosidenib"],"drugbank":["DB14568"]},"count":7,"approvedIndications":["EFO_0000616","EFO_0000222"],"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0001421","EFO_0000326","EFO_0000222","EFO_0002427","EFO_0005221","EFO_0000333"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neoplasm and acute myeloid leukemia and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989960","canonicalSmiles":"CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1.NCCCC[C@H](N)C(=O)O.O.O","inchiKey":"WTKSWPYGZDCUNQ-JZXFCXSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELADELPAR LYSINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL230158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBX-8025 lysine","Seladelpar lysine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403328","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"XLPGURCDSRIXFL-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403328","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403673","canonicalSmiles":"COc1ccc(Nc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1Cl","inchiKey":"ZVWFECUPYCFYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403673","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408194","canonicalSmiles":"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\\c1[nH]c(C)cc1C","inchiKey":"RFTSSZJZXOSICM-GRSHGNNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBATOCLAX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GX15-070","Obatoclax"],"crossReferences":{"drugbank":["DB12191"]},"childChemblIds":["CHEMBL2107358"],"count":2,"linkedTargets":{"rows":["ENSG00000140379","ENSG00000171552","ENSG00000258643","ENSG00000171791","ENSG00000137875","ENSG00000143384","ENSG00000129473"],"count":7},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0044903","EFO_0001642","EFO_0000403","EFO_0000222","EFO_1001469","MONDO_0001023","EFO_0000095","MONDO_0008903","EFO_0000702","MONDO_0018906","EFO_0001378","EFO_0000183","EFO_0002617"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4091374","canonicalSmiles":"O=C(O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1","inchiKey":"OQDQIFQRNZIEEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANIFIBRANOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IVA-337","IVA337","Iva337","Lanifibranor"],"crossReferences":{"drugbank":["DB14801"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL41342","canonicalSmiles":"CC(C)=CCC/C(C)=C/COP(=O)(O)OP(=O)(O)O","inchiKey":"GVVPGTZRZFNKDS-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GERANYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Geranyl Diphosphate"],"crossReferences":{"Wikipedia":["Geranyl_pyrophosphate"],"drugbank":["DB02552"],"chEBI":["17211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4164059","canonicalSmiles":"Cl.Clc1ccc(CCCOCCCN2CCCCC2)cc1","inchiKey":"XLFKECRRMPOAQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITOLISANT HYDROCHLORIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL462605","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Wakix"],"synonyms":["Pitolisant hydrochloride"],"crossReferences":{"DailyMed":["pitolisant%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0005246","EFO_0000614"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0005246","EFO_0000614"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for narcolepsy with cataplexy and hypersomnia."}
{"id":"CHEMBL425863","canonicalSmiles":"C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21","inchiKey":"PTQMMNYJKCSPET-OMHQDGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIBOLERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mibolerone","U-10,997"],"crossReferences":{"PubChem":["170466095"],"Wikipedia":["Mibolerone"],"drugbank":["DB11429"],"chEBI":["34849"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297364","canonicalSmiles":"CC[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"NVOYVOBDTVTBDX-AGUVMIOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITROPIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxitropium"],"childChemblIds":["CHEMBL4297109"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4297396","canonicalSmiles":"Cl.N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1","inchiKey":"YNBSQYGTJLIPJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-778123","maximumClinicalTrialPhase":1,"parentId":"CHEMBL279433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-778,123","L-778123"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297510","canonicalSmiles":"O=C(NCCS)c1cccc(C(=O)NCCS)c1","inchiKey":"JUTBAVRYDAKVGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMERAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emeramide"],"crossReferences":{"drugbank":["DB12192"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297513","canonicalSmiles":"CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(C)COC[C@@]4(C[C@@H](n4ncnc4-c4ccncc4)[C@@H]5OC[C@](C)(N)C(C)(C)C)C3=CC[C@@]2(C)[C@@H]1C(=O)O","inchiKey":"BODYFEUFKHPRCK-ZCZMVWJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBREXAFUNGERP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibrexafungerp","MK 3118","MK-3118","MK-3118 FREE BASE","SCY-078","Scy-078"],"crossReferences":{"drugbank":["DB12471"]},"childChemblIds":["CHEMBL4298168"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4297514","canonicalSmiles":"C[C@H]1N=C(N(C)C)N=C(N)N1","inchiKey":"GFICWFZTBXUVIG-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMEGLIMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-387008","Imeglimin"],"crossReferences":{"drugbank":["DB12509"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297552","drugType":"Unknown","blackBoxWarning":false,"name":"AMV-564","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMV-564","AMV564","Amv-564","Amv564","CNTO 3953 TANDAB","CNTO-3953","T-652","T652"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297596","canonicalSmiles":"Cn1c(=O)oc2cc(-n3cc(C(=O)O)c(=O)n([C@@H]4CCc5c4cccc5C(F)(F)F)c3=O)ccc21","inchiKey":"JDARDSVOVYVQST-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FULACIMSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1142524","BAY1142524","Bay1142524","Fulacimstat"],"crossReferences":{"drugbank":["DB15085"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297696","drugType":"Unknown","blackBoxWarning":false,"name":"AR-105","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-105","Ar-105"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297735","drugType":"Unknown","blackBoxWarning":false,"name":"CURDLAN SULFATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Curdlan sulfate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297859","drugType":"Antibody","blackBoxWarning":false,"name":"AZINTUXIZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abbv-838","Azintuxizumab vedotin"],"count":1,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000026751","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297889","drugType":"Unknown","blackBoxWarning":false,"name":"AVACINCAPTAD PEGOL SODIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC-1905","ARC1905","Arc1905","Avacincaptad pegol sodium"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297948","drugType":"Unknown","blackBoxWarning":false,"name":"ERY-974","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERY-974","ERY974","Ery-974","Ery974"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297953","drugType":"Unknown","blackBoxWarning":false,"name":"ANTI-INHIBITOR COAGULANT COMPLEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-inhibitor coagulant complex","Factor viii inhibitor bypassing fraction","Feiba"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298176","drugType":"Antibody","blackBoxWarning":false,"name":"GARETOSMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Garetosmab","REGN-2477","REGN2477"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4303721","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)O)[C@H]3SC2)cc1.O.[Na+]","inchiKey":"XTRRFIYXAPRYES-NLFZDHTNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303721","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3351077","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O","inchiKey":"JZUFKLXOESDKRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCHLOROTHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apo-hydro","Esidrex","Esidrix","Hydro-d","Hydrochlorothiazide","Hydrochlorothiazide intensol","Hydrodiuril","Hydrosaluric","Microzide","Oretic","Zide"],"synonyms":["Hctz","Hydrochlorothiazide","NSC-53477","SU-5879"],"crossReferences":{"DailyMed":["hydrochlorothiazide"],"PubChem":["103995","11111269","11111270","144208763","144210612","170465005","17389854","26746944","50103978","85231074","855646"],"Wikipedia":["Hydrochlorothiazide"],"drugbank":["DB00999"],"chEBI":["5778"]},"count":20,"approvedIndications":["EFO_0001422","EFO_0003884","EFO_0004255","EFO_0000373","EFO_0000612","EFO_0000319","MONDO_0002462","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0003124","EFO_0000401","EFO_0004278","EFO_0001645","EFO_0000373","EFO_0000319","MONDO_0002462","EFO_0000537","EFO_0003913","EFO_0003914","EFO_0001422","EFO_0000195","HP_0002900","Orphanet_79292","EFO_0003144","EFO_0004253","EFO_0003884","EFO_0004255","EFO_1002032","EFO_0000612","EFO_0001360","EFO_0003918","EFO_0000400","EFO_0000668"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 9 approved and 11 investigational indications."}
{"id":"CHEMBL437508","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O","inchiKey":"OIMACDRJUANHTJ-XPWFQUROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01717"],"chEBI":["28898"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594348","canonicalSmiles":"C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1","inchiKey":"UNHZLHSLZZWMNP-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSUBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elsubrutinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594467","drugType":"Unknown","blackBoxWarning":false,"name":"CC-90006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-90006","Cc-90006"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594589","drugType":"Unknown","blackBoxWarning":false,"name":"RETINOIC ACID RECEPTOR .GAMMA.","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rar gamma","Retinoic acid receptor .gamma."],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL462313","canonicalSmiles":"CC(C)N[C@@H]1CCn2c(=O)[nH]c3cccc(c32)[C@H]1O","inchiKey":"ZSTCZWJCLIRCOJ-DGCLKSJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Zilpaterol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zilpaterol"],"crossReferences":{"drugbank":["DB11479"]},"childChemblIds":["CHEMBL513390"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL465123","canonicalSmiles":"NCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"WIQRCHMSJFFONW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPROXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seproxetine"],"crossReferences":{"drugbank":["DB06731"]},"childChemblIds":["CHEMBL2107550"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478649","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1","inchiKey":"BOPSUAHGQHFKGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07835"],"chEBI":["90527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL493737","canonicalSmiles":"CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"DSCFFEYYQKSRSV-KLJZZCKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLINOSITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cathrtomannitol","D-Pinitol","Methylinositol","NDI 18","NIC5-15","NSC-128700","Nic5-15","Pinitol"],"crossReferences":{"Wikipedia":["Pinitol"],"drugbank":["DB12969"],"chEBI":["28548"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL537649","canonicalSmiles":"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1.Cl","inchiKey":"HIWSKCRHAOKBSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANOLAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1404","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["46500415"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539165","canonicalSmiles":"Oc1ccc(C(F)(F)F)cc1","inchiKey":"BAYGVMXZJBFEMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-1C13","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-1C13"],"crossReferences":{"drugbank":["DB03610"],"chEBI":["42578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556578","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.Cl","inchiKey":"XCKKIKBIPZJUET-VYKNHSEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL70","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Morph hcl"],"synonyms":["Morphine Hydro Chloride","Morphine hydrochloride","Morphine hydrochloride hydrate","Morphine hydrochloride trihydrate"],"crossReferences":{"chEBI":["55340"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL577120","canonicalSmiles":"N#Cc1c[nH]c2nc(N)[nH]c(=O)c12","inchiKey":"FMKSMYDYKXQYRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL577120","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03074"],"chEBI":["45075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL707","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC","inchiKey":"RUZYUOTYCVRMRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAZOSIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C02CA04","Cardura","Doxazosin","UK-33274"],"crossReferences":{"DailyMed":["doxazosin%20mesylate"],"PubChem":["124883384","50105246","90341261"],"Wikipedia":["Doxazosin"],"drugbank":["DB00590"],"chEBI":["4708"]},"childChemblIds":["CHEMBL1200561"],"count":15,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003777","EFO_0002610","HP_0003124","EFO_0000401","EFO_0004234","EFO_0003768","EFO_0000284","EFO_0001358","EFO_0009094","EFO_0000537","EFO_0003829","EFO_0003890","MONDO_0002491","EFO_1001375","EFO_0003144","EFO_0004253","EFO_0000612","EFO_0000400","EFO_0000239"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for hypertension and has 14 investigational indications."}
{"id":"CHEMBL708","canonicalSmiles":"O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"MVWVFYHBGMAFLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIPRASIDONE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-88059","Geodon","Ziprasidone"],"crossReferences":{"DailyMed":["ziprasidone%20hydrochloride","ziprasidone%20mesylate"],"PubChem":["144205747","144207074","170465342","26719835"],"Wikipedia":["Ziprasidone"],"drugbank":["DB00246"],"chEBI":["10119"]},"childChemblIds":["CHEMBL1712","CHEMBL1200997","CHEMBL3989833","CHEMBL1375743"],"count":14,"approvedIndications":["EFO_0005407","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0002009","HP_0012076","HP_0000726","EFO_0000677","EFO_0003758","EFO_0005407","EFO_0000319","EFO_1001917","EFO_0004247","EFO_0000289","EFO_0003890","MONDO_0002050","EFO_0005611","EFO_0005230","EFO_0000692","EFO_0005411"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for schizoaffective disorder and psychosis and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL776","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1","inchiKey":"LMOINURANNBYCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metaproterenol","Orciprenaline"],"crossReferences":{"DailyMed":["metaproterenol%20sulfate"],"PubChem":["26748125","90340962"],"Wikipedia":["Orciprenaline"],"drugbank":["DB00816"],"chEBI":["6792"]},"childChemblIds":["CHEMBL1200812","CHEMBL1568057","CHEMBL2164775"],"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0003890","EFO_0000270"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973 and is indicated for airway obstruction."}
{"id":"CHEMBL77675","canonicalSmiles":"N=C(Nc1ccccc1)Nc1ccccc1","inchiKey":"OWRCNXZUPFZXOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N,N'-Diphenyl-Guanidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N'-Diphenyl-Guanidine"],"crossReferences":{"PubChem":["144204549","144214002","170465656","17389460","26752749","49671529","49826097"],"drugbank":["DB14191"]},"childChemblIds":["CHEMBL556117"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL81273","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc([C@@H](O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"AYAJZQYENGWICE-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL81273","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03466"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL86882","canonicalSmiles":"CCNCC(O)c1cccc(O)c1","inchiKey":"SQVIAVUSQAWMKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETILEFRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Effortil","Effortil depot perlongetten"],"synonyms":["Etilefrine","Etilefrine hydrochloride"],"crossReferences":{"PubChem":["50085437"],"Wikipedia":["Etilefrine"],"drugbank":["DB08985"]},"childChemblIds":["CHEMBL3187408"],"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL88153","canonicalSmiles":"COc1ccc(C(CC(N)=O)N2C(=O)c3ccccc3C2=O)cc1OC1CCCC1","inchiKey":"DDYUBCCTNHWSQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CDC-801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-1088","CDC-801","CDC801","Cdc-801"],"crossReferences":{"drugbank":["DB15640"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL93247","canonicalSmiles":"N/C(S)=N/CCC[C@H](N)C(=O)O","inchiKey":"BKGWACHYAMTLAF-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93247","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756870","90341707"],"drugbank":["DB03953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93747","canonicalSmiles":"O=C1NC(=O)C(Cc2ccc3cc(OCc4ccccc4F)ccc3c2)S1","inchiKey":"PKWDZWYVIHVNKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETOGLITAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCC 555","Mcc-555","Netoglitazone","PGX-510","RWJ-241947"],"crossReferences":{"drugbank":["DB09199"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL94454","canonicalSmiles":"CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1","inchiKey":"PVLJETXTTWAYEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIZOLASTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mizollen"],"synonyms":["Mizolastine"],"crossReferences":{"PubChem":["144206216","170465604","50125752"],"Wikipedia":["Mizolastine"],"drugbank":["DB12523"]},"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergy."}
{"id":"CHEMBL947","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21","inchiKey":"GECBBEABIDMGGL-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CESAMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nabilone"],"crossReferences":{"Wikipedia":["Nabilone"],"drugbank":["DB00486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL95606","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"UHDGCWIWMRVCDJ-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine","MMV638723","NSC-20258"],"crossReferences":{"PubChem":["26754267","93576752"],"Wikipedia":["Cytidine"],"drugbank":["DB02097"],"chEBI":["17562"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
